Screening for Ocult Renal Disease (SCORED): marcadores associados ao diagnóstico e à mortalidade após dez anos de avaliação
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Chronic kidney disease (CKD) is subject to population screening as it is
serious, frequent and meets the epidemiological criteria that classify the need for
screening for a pathology. In Brazil, according to the 2022 survey on patients on
dialysis therapy, it was estimated that there were more than 150 thousand patients
on dialysis. The main causes of CKD are Diabetes Mellitus (DM) and Systemic
Arterial Hypertension (SAH) and, in the context of these pathologies, factors that are
associated with worse disease progression are uncontrolled SAH, proteinuria,
anemia, acidemia, hyperuricemia, among others. Some factors, such as the
presence of glomerular hematuria (HtG) in the urinary sediment, have a wellestablished importance in the context of immunoglobulin A glomerulopathy, however,
their importance in the general condition of CKD is still controversial. In 2014, a study
was carried out at the Federal University of Juiz de Fora to validate the Screening for
Occult Renal Disease (SCORED) questionnaire in the general population. The
objective of this study was to evaluate whether sociodemographic factors and the
presence of hematuria are associated with mortality in CKD and whether there is a
variation in the disease's diagnostic markers, making it therefore necessary to
measure them at two moments during CKD screening. A prospective cohort study
was carried out from 2011 to 2022. Participants who took part in the SCORED study
were included and, in Phase 1, sociodemographic, clinical, pathological and
laboratory variables were evaluated. In the second Phase, the outcome is death. A
descriptive statistical analysis was carried out, the variables associated with the CKD
diagnostic criteria were compared over a three-month interval. Individuals with and
without CKD were compared; survivors and non-survivors by Chi-Square, Fisher, tStudent or ANOVA tests. And, finally, factors associated with survival adjusted for
confounders by a Cox Regression model. Considered a 95.0% confidence interval.
The initial sample size was six hundred participants and CKD was diagnosed, in the
first examination, using the criteria of estimated glomerular filtration (FGe) 60
mL/min/1.73 m2
in 8.8%, Albumin/Creatinine Ratio (ACR) altered in 5.0% and
presence of HtG in 16.3%, having been confirmed in the second exam using the
same criteria: FGe 60 mL/min/1.73 m2
in 3.5%, RAC altered in 3.0 % and presence
of HtG in 9.5%. Regarding CKD non-CKD, a higher prevalence was observed in
non-whites and the elderly; laboratory results, higher levels of total cholesterol and
LDL cholesterol. In the second Phase, a sample of 103 participants was obtained,
comparing death to non-death. The sociodemographic, clinical and pathological
variables that were associated with death were older people, lower income, higher
systolic and diastolic blood pressure, personal history of SAH, DM, coronary disease
and smoking. In the laboratory, higher levels of uric acid and blood glucose. Only age
and HtG were predictors of mortality. It was concluded that there was variability in the
diagnostic markers of CKD, thus reinforcing the importance of being evaluated at two
moments. HtG was not only the diagnostic marker with the least variability, but also a
marker of mortality.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

